Cargando…
Parkinson’s Disease: Are PINK1 Activators Inching Closer to the Clinic?
[Image: see text] The activation of PINK1 by small molecules has emerged as a promising strategy in treating Parkinson’s disease (PD). Recent progress in this area has raised excitement around PINK1 activators as PD treatments, and herein we offer insight into these developments and their potential...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Chemical Society
2023
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350934/ https://www.ncbi.nlm.nih.gov/pubmed/37465300 http://dx.doi.org/10.1021/acsmedchemlett.3c00070 |